To generate long-term capital appreciation by investing predominantly in equity & equity related instruments across market capitalization i.e. large-cap, mid-cap and small-cap stocks. However, there is no assurance or guarantee that the investment objective of the Scheme will be achieved.
Expert-managed portfolios tailored to your financial goals and risk appetite.
| Flexi Cap Fund | 1M | 3M | 6M | 9M | 1Y | 2Y | 3Y | 4Y | 5Y | 10Y | ALL |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Fund returns | -3.94% | -1.32% | -1.76% | -4.29% | -2.62% | N/A | N/A | N/A | N/A | N/A | -1.63% |
| Category returns | -3.55% | -3.47% | 0.22% | -1.36% | -3.47% | -1.74% | 9.93% | 11.32% | 8.27% | 12.15% | N/A |
| Absolute returns | -3.94% | -1.32% | -1.76% | -4.29% | -2.62% | N/A | N/A | N/A | N/A | N/A | -1.96% |
| Rank within category | 32/47 | 8/45 | 29/45 | 28/44 | 14/43 | N/A | N/A | N/A | N/A | N/A | N/A |
| Flexi Cap Fund | 2025 | 2026 |
|---|---|---|
| Yearly returns | N/A | -4.05% |
| Q1 returns | N/A | -7.84% |
| Q2 returns | N/A | 5.25% |
| Q3 returns | N/A | 0.83% |
| Q4 returns | 6.17% | -1.89% |
1% on or before 1M, Nil after 1M
| Alpha | -0.0547959 |
| Beta | 0.6026 |
| Sharpe Ratio | -0.144931 |
| Sortino Ratio | -0.227716 |
| R-Squared | 0.7277 |
| Tracking Error | 2.0648 |
| Downside Risk | 10.2362 |
| Std. Deviation (Annualised) | 9.3447 |
| Flexi Cap Fund | 1M | 3M | 6M | 9M | 1Y | 3Y | 5Y | 10Y | ALL | Fund Size (Cr) | Exp. Ratio | Sharpe | Risk |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bank of India Flexi Cap Fund - Regular Plan - Growth | -3.35% | -1.43% | 2.99% | 7.46% | 5.12% | 16% | 12.94% | N/A | 23.14% | 3,098.01 | 2.25 | 0.19 | Very High |
| Motilal Oswal Flexi Cap Fund - Regular Plan - Growth | -3.96% | 0.29% | 7.14% | 1.84% | -3.44% | 15.67% | 10.74% | 11.39% | 15.55% | 13,446.10 | 2.05 | 0.20 | Very High |
| ITI Flexi Cap Fund - Regular Plan - Growth | -3.29% | -1.32% | 7.27% | 7.27% | 5.9% | 15.45% | N/A | N/A | 19.43% | 1,588.28 | 2.34 | 0.20 | Very High |
| Invesco India Flexi Cap Fund - Regular Plan - Growth | -4.08% | -3.78% | 3.34% | 1.53% | -5.11% | 14.22% | N/A | N/A | 14.13% | 5,436.64 | 2.08 | 0.17 | Very High |
| 360 ONE Flexicap Fund - Regular Plan - Growth | -3.1% | 0.17% | 6.96% | 6.97% | 2.84% | 14.09% | N/A | N/A | 14.9% | 2,245.86 | 2.38 | 0.18 | Very High |
| HDFC Flexi Cap Fund - Growth | -3.64% | -4% | -1.65% | -5.02% | -5.14% | 13.66% | 13.68% | 14.29% | 18.05% | 108,547.00 | 1.37 | 0.19 | Very High |
| HSBC Flexi Cap Fund - Regular Plan - Growth | -3.58% | -0.69% | 2.62% | 2.59% | 0.36% | 13.63% | 10.25% | 11.75% | 14.71% | 5,748.74 | 2.10 | 0.17 | Very High |
| Bajaj Finserv Flexi Cap Fund - Regular Plan - Growth | -4.03% | -4.7% | 1.01% | 1.23% | -1.03% | 13.48% | N/A | N/A | 13.26% | 8,527.48 | 2.22 | 0.17 | Very High |
| ICICI Prudential Flexi Cap Fund - Growth | -3.5% | -1.75% | 1.98% | 1.29% | -2% | 13.3% | 12.22% | N/A | 13.66% | 25,140.90 | 1.73 | 0.17 | Very High |
| Capitalmind Flexi Cap Fund - Regular Plan - Growth Current | -3.94% | -1.32% | -1.76% | -4.29% | -2.62% | N/A | N/A | N/A | -1.63% | 461.71 | 3.16 | -0.14 | Very High |
| Name | Sector | Instrument | Assets % |
|---|---|---|---|
| Welspun Corp Ltd. | Industrial Products | Domestic Equities | 6.31% |
| Laurus Labs Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 4.42% |
| Clearing Corporation of India Ltd | Cash & Cash Equivalents and Net Assets | 4.17% | |
| Divi's Laboratories Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 3.90% |
| Bank Of Maharashtra | Banks | Domestic Equities | 3.79% |
| The Federal Bank Ltd. | Banks | Domestic Equities | 3.65% |
| RR Kabel Ltd. | Industrial Products | Domestic Equities | 3.54% |
| Torrent Pharmaceuticals Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 3.47% |
| Karur Vysya Bank Ltd. | Banks | Domestic Equities | 3.33% |
| The Karnataka Bank Ltd. | Banks | Domestic Equities | 3.30% |
| Multi Commodity Exchange Of India Ltd. | Capital Markets | Domestic Equities | 3.28% |
| Anand Rathi Wealth Ltd. | Capital Markets | Domestic Equities | 3.28% |
| Radico Khaitan Ltd. | Beverages | Domestic Equities | 3.21% |
| Granules India Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 3.20% |
| Bajaj Auto Ltd. | Automobiles | Domestic Equities | 3.18% |
| Samvardhana Motherson International Ltd. | Auto Components | Domestic Equities | 3.16% |
| RBL Bank Ltd. | Banks | Domestic Equities | 3.07% |
| Bosch Ltd. | Auto Components | Domestic Equities | 3.06% |
| Sona BLW Precision Forgings Ltd. | Auto Components | Domestic Equities | 3.05% |
| Titan Company Ltd. | Consumer Durables | Domestic Equities | 3.03% |
| Sai Life Sciences Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 3.02% |
| PNB Housing Finance Ltd. | Finance | Domestic Equities | 2.99% |
| Aurobindo Pharma Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 2.95% |
| FSN E-Commerce Ventures Ltd. | Retailing | Domestic Equities | 2.89% |
| Bharat Forge Ltd. | Auto Components | Domestic Equities | 2.88% |
| Apollo Hospitals Enterprise Ltd. | Healthcare Services | Domestic Equities | 2.81% |
| Anthem Biosciences Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 2.78% |
| Himadri Speciality Chemical Ltd. | Chemicals & Petrochemicals | Domestic Equities | 2.77% |
| Zydus Lifesciences Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 2.76% |
| Grasim Industries Ltd. | Cement & Cement Products | Domestic Equities | 2.51% |
| Oracle Financial Services Software Ltd. | IT - Software | Domestic Equities | 0.43% |
| 364 Days Tbill (MD 25/12/2026) | Treasury Bills | 0.07% | |
| Net Receivables / (Payables) | Cash & Cash Equivalents and Net Assets | -0.26% | |
| Total | 100.00% | ||
Prateek Jain, CFA, is an experienced investment professional with a strong background in fixedincome portfolio management and trading. In his previous organisation, Invesco Asset Management, he served as a Fund Manager and Fixed-Income Dealer, overseeing liquid fund and overnight fund as Fund Manager. His responsibilities included duration and asset allocation strategies, yield-curve positioning, daily cash-flow management, and trading.
Overall 3.5 years of experience across Capitalmind Asset Management Pvt. Ltd. and Capitalmind Financial Services. Currently designated as Associate Fund Manager, handling portfolio construction, rebalancing, monitoring & performance attribution; previously Quantitative Analyst (Aug 2025 - Mar 2026), Research Analyst (Dec 2023 - Jul 2025), and Junior Research Analyst (Sep 2022 - Nov 2023) with experience in cross-asset strategy design, model development, portfolio analytics, and equity/macro research.
Get personalized portfolio management services designed to grow and protect your wealth.
ChatGPT
Claude
Perplexity
